作者
Donna L Thibault, Alvina D Chu, Kareem L Graham, Imelda Balboni, Lowen Y Lee, Cassidy Kohlmoos, Angela Landrigan, John P Higgins, Robert Tibshirani, Paul J Utz
发表日期
2008/4/1
期刊
The Journal of clinical investigation
卷号
118
期号
4
页码范围
1417-1426
出版商
American Society for Clinical Investigation
简介
A hallmark of SLE is the production of high-titer, high-affinity, isotype-switched IgG autoantibodies directed against nucleic acid–associated antigens. Several studies have established a role for both type I IFN (IFN-I) and the activation of TLRs by nucleic acid–associated autoantigens in the pathogenesis of this disease. Here, we demonstrate that 2 IFN-I signaling molecules, IFN regulatory factor 9 (IRF9) and STAT1, were required for the production of IgG autoantibodies in the pristane-induced mouse model of SLE. In addition, levels of IgM autoantibodies were increased in pristane-treated Irf9–/– mice, suggesting that IRF9 plays a role in isotype switching in response to self antigens. Upregulation of TLR7 by IFN-α was greatly reduced in Irf9–/– and Stat1–/– B cells. Irf9–/– B cells were incapable of being activated through TLR7, and Stat1–/– B cells were impaired in activation through both TLR7 and TLR9. These …
引用总数
200820092010201120122013201420152016201720182019202020212022202320242111212166241053738722
学术搜索中的文章
DL Thibault, AD Chu, KL Graham, I Balboni, LY Lee… - The Journal of clinical investigation, 2008